{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:38:34Z","timestamp":1648849114064},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008464","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T22:01:19Z","timestamp":1509573679000},"page":"e8464","source":"Crossref","is-referenced-by-count":1,"title":["Everolimus for pediatric patients with acute graft-versus-host disease after hematopoietic stem cell transplantation"],"prefix":"10.1097","volume":"96","author":[{"given":"Yu-Hua","family":"Chao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Tien","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Te-Fu","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-Hsi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-48-20210226","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/cncr.20613","article-title":"Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management","volume":"101","author":"Couriel","year":"2004","journal-title":"Cancer"},{"key":"R2-48-20210226","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1182\/blood-2006-12-041889","article-title":"How I treat refractory acute GVHD","volume":"109","author":"Deeg","year":"2007","journal-title":"Blood"},{"key":"R3-48-20210226","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbmt.2012.06.020","article-title":"Defining the role of sirolimus in the management of graft-versus-host disease: from prophylaxis to treatment","volume":"19","author":"Abouelnasr","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R4-48-20210226","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bbmt.2015.01.001","article-title":"A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality","volume":"21","author":"MacMillan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R5-48-20210226","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/petr.12009","article-title":"Acute graft-versus-host disease in pediatric allogeneic hematopoietic stem cell transplantation. Single-center experience during 10 yr","volume":"16","author":"Faraci","year":"2012","journal-title":"Pediatr Transplant"},{"key":"R6-48-20210226","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.transproceed.2007.09.008","article-title":"Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy","volume":"39","author":"Chapman","year":"2007","journal-title":"Transplant Proc"},{"key":"R7-48-20210226","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-48-20210226","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00467-013-2505-9","article-title":"mTOR inhibitors in pediatric kidney transplantation","volume":"29","author":"Pape","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R9-48-20210226","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MOT.0000000000000127","article-title":"Everolimus in liver transplantation","volume":"19","author":"Trotter","year":"2014","journal-title":"Curr Opin Organ Transpl"},{"key":"R10-48-20210226","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbmt.2008.11.004","article-title":"Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial","volume":"15","author":"Platzbecker","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"R11-48-20210226","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/bmt.2014.170","article-title":"Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: a dual center retrospective analysis","volume":"49","author":"Mielke","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R12-48-20210226","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bbmt.2010.07.025","article-title":"Therapy of sclerodermatous chronic graft-versus-host disease with mammalian target of rapamycin inhibitors","volume":"17","author":"Jedlickova","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R13-48-20210226","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/ctr.12472","article-title":"Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus","volume":"28","author":"Lutz","year":"2014","journal-title":"Clin Transplant"},{"key":"R14-48-20210226","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol"},{"key":"R15-48-20210226","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"R16-48-20210226","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R17-48-20210226","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3324\/haematol.2011.041236","article-title":"Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids","volume":"96","author":"Pidala","year":"2011","journal-title":"Haematologica"},{"key":"R18-48-20210226","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbmt.2009.03.020","article-title":"Sirolimus as primary treatment of acute graft-versus-host disease following allogeneic hematopoietic cell transplantation","volume":"15","author":"Pidala","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"R19-48-20210226","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1097\/00007890-200112270-00010","article-title":"Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease","volume":"72","author":"Benito","year":"2001","journal-title":"Transplantation"},{"key":"R20-48-20210226","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/TP.0b013e3181ba0a13","article-title":"Rapamycin for refractory acute graft-versus-host disease","volume":"88","author":"Ghez","year":"2009","journal-title":"Transplantation"},{"key":"R21-48-20210226","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/bmt.2009.343","article-title":"Sirolimus for treatment of steroid-refractory acute graft-versus-host disease","volume":"45","author":"Hoda","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R22-48-20210226","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.2005.05616.x","article-title":"Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease","volume":"130","author":"Couriel","year":"2005","journal-title":"Br J Haematol"},{"key":"R23-48-20210226","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbmt.2007.02.003","article-title":"Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease","volume":"13","author":"Jurado","year":"2007","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:38:52Z","timestamp":1620959932000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711030-00048"}},"subtitle":["A pilot study"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":23,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008464","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}